Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Glioblastoma”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Study completedNCT00003141
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma+1 more
Children's Oncology Group 94
Testing effectiveness (Phase 2)Looking for participantsNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT01975701
What this trial is testing

BGJ398 in Patients With Recurrent GBM

Who this might be right for
Recurrent Glioblastoma or Other Glioma Subtypes
Novartis Pharmaceuticals 26
Early research (Phase 1)Study completedNCT04908176
What this trial is testing

A Drug-drug Interaction Study of Avapritinib and Midazolam

Who this might be right for
Gastrointestinal Stromal TumorsGISTNon-resectable Advanced Solid Tumors+1 more
Blueprint Medicines Corporation 10
Testing effectiveness (Phase 2)Ended earlyNCT04209790
What this trial is testing

Neoadjuvant Chemoradiation for Resectable Glioblastoma

Who this might be right for
GlioblastomaSurgeryHigh Grade Glioma
Geisinger Clinic 2
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)WithdrawnNCT00083447
What this trial is testing

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Xenova Biomedix 323
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Early research (Phase 1)Study completedNCT00979173
What this trial is testing

Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

Who this might be right for
Glioma
Annick Desjardins 5
Testing effectiveness (Phase 2)Study completedNCT01100177
What this trial is testing

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 12
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Early research (Phase 1)Active Not RecruitingNCT04003649
What this trial is testing

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Testing effectiveness (Phase 2)Study completedNCT00005955
What this trial is testing

Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Duke University
Large-scale testing (Phase 3)Study completedNCT00088400
What this trial is testing

Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors

Who this might be right for
Glioblastoma
National Institute of Neurological Disorders and Stroke (NINDS) 30
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Early research (Phase 1)Study completedNCT01811992
What this trial is testing

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Who this might be right for
Malignant GliomaGlioblastoma Multiforme
University of Michigan Rogel Cancer Center 19
Load More Results